EMV Capital plc

EMV Capital plc is a UK-based venture capital firm specializing in investments at seed, early, and mid stages, with a strategic focus on deep tech and life sciences sectors. The company targets high-growth, IP-rich startups in areas such as sustainability, life sciences, transformative biomedical technologies, semiconductors, industrial robotics, artificial intelligence, and healthcare innovations including digital health, diagnostics, and therapeutics. It prioritizes investments in firms that enhance chronic disease management through data analytics, wearable devices, and other advanced technologies. EMV Capital combines a capital-efficient investment strategy—utilizing its balance sheet, syndicate investments, and fund management—with proactive portfolio management, taking active board roles to drive growth and value creation. The firm operates primarily in European developed markets, the UK, and the US, aiming to lead the next wave of venture capital by advancing early-stage companies to critical value inflection points. Founded in 2008 and headquartered in London, EMV Capital balances direct equity stakes with carried interest from third-party funds, emphasizing sustainable growth and superior returns within cutting-edge technology domains.